Here's the live share price of Piramal Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Piramal Pharma | 0.68 | 9.80 | 20.89 | 5.51 | -11.85 | 25.68 | -1.11 |
| Sun Pharmaceutical Industries | 1.61 | 7.86 | 17.15 | 11.42 | 15.71 | 22.76 | 23.67 |
| Divi's Laboratories | 1.06 | 2.72 | 12.52 | 5.30 | -0.01 | 23.33 | 8.29 |
| Torrent Pharmaceuticals | 2.72 | 7.12 | 17.14 | 23.98 | 47.75 | 36.78 | 26.59 |
| Cipla | -1.35 | 4.03 | 18.78 | -1.86 | -3.12 | 12.28 | 8.44 |
| Zydus Lifesciences | 0.83 | 4.06 | 24.63 | 28.55 | 17.45 | 25.56 | 12.26 |
| Lupin | 0.84 | 9.80 | 7.98 | 14.03 | 31.92 | 40.48 | 16.73 |
| Mankind Pharma | -0.18 | 6.53 | 21.51 | 13.46 | -2.00 | 13.54 | 12.15 |
| Dr. Reddy's Laboratories | -9.39 | -2.32 | 0.83 | 2.46 | -0.68 | 6.50 | 2.55 |
| Aurobindo Pharma | -3.24 | 7.07 | 17.02 | 33.68 | 39.41 | 28.71 | 10.76 |
| Laurus Labs | -0.50 | 10.32 | 41.00 | 47.17 | 93.92 | 62.43 | 17.77 |
| Biocon | -1.71 | 0.52 | 21.45 | 12.61 | 12.14 | 18.09 | 1.58 |
| Alkem Laboratories | 1.87 | 7.04 | 5.88 | -3.30 | 18.06 | 17.66 | 11.07 |
| Glenmark Pharmaceuticals | 3.00 | 6.14 | 3.74 | 12.78 | 4.33 | 50.75 | 28.25 |
| Abbott India | 4.93 | 4.03 | 5.44 | -4.54 | -21.17 | 4.97 | 9.43 |
| Ipca Laboratories | 0.33 | 10.77 | 23.16 | 16.91 | 23.29 | 33.26 | 11.05 |
| Anthem Biosciences | -1.85 | -3.14 | 3.52 | 22.32 | 3.44 | 1.13 | 0.68 |
| Ajanta Pharma | 1.02 | 7.00 | 16.02 | 22.89 | 27.84 | 33.64 | 18.48 |
| GlaxoSmithKline Pharmaceuticals | 1.79 | 15.83 | 1.06 | 1.54 | -24.88 | 20.37 | 10.22 |
| Gland Pharma | 0.71 | 7.48 | 43.93 | 45.49 | 33.29 | 31.69 | -7.19 |
Source: Dion Global
Over the last one year, Piramal Pharma has declined 11.85% compared to peers like Sun Pharmaceutical Industries (15.71%), Divi's Laboratories (-0.01%), Torrent Pharmaceuticals (47.75%). From a 5 year perspective, Piramal Pharma has underperformed peers relative to Sun Pharmaceutical Industries (23.67%) and Divi's Laboratories (8.29%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 173.78 | 173.6 |
| 10 | 170.81 | 171.99 |
| 20 | 167.33 | 170.18 |
| 50 | 169.8 | 167.45 |
| 100 | 160.53 | 166.43 |
| 200 | 171.59 | 171.96 |
Source: Dion Global
In the latest quarter, Piramal Pharma remained same as its previous close in promoter holding, while DII stake decreased to 15.61%, FII holding rose to 30.17%, and public shareholding moved down to 19.01% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 98,96,924 | 0.63 | 171.01 | |
| 61,54,389 | 1.22 | 106.34 | |
| 42,36,313 | 0.41 | 73.2 | |
| 33,34,415 | 0.42 | 57.62 | |
| 14,97,727 | 0.29 | 25.88 | |
| 10,91,460 | 0.24 | 18.86 | |
| 8,75,000 | 0.09 | 15.12 | |
| 7,82,387 | 0.2 | 13.52 | |
| 6,05,456 | 1.51 | 10.46 | |
| 4,59,534 | 1.55 | 7.94 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 03, 2026, 10:07 PM IST IST | Piramal Pharma - Business Responsibility and Sustainability Reporting (BRSR) |
| Jul 03, 2026, 09:02 PM IST IST | Piramal Pharma - Reg. 34 (1) Annual Report. |
| Jul 03, 2026, 08:46 PM IST IST | Piramal Pharma - Notice Of The 6Th Annual General Meeting And Annual Report For The Financial Year 2025-26 |
| Jun 23, 2026, 10:04 PM IST IST | Piramal Pharma - Clarification On News Item Appearing On NDTV Profit Captioned - "Piramal Pharma Share Price Spikes Over 10% |
| Jun 23, 2026, 06:56 PM IST IST | Piramal Pharma - Clarification sought from Piramal Pharma Ltd |
Source: Dion Global
Piramal Pharma Ltd. is a Public Limited Listed company incorporated on 04/03/2020 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U24297MH2020PLC338592 and registration number is 338592. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 4782.01 Cr. and Equity Capital is Rs. 1327.16 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Piramal Pharma is ₹177.10 as on Jul 10, 2026.
The Piramal Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Piramal Pharma is ₹23,578.18 Cr as on Jul 10, 2026.
Today’s highest and lowest price of Piramal Pharma are ₹177.90 and ₹171.90.
The 52-week high/low is the highest and lowest price at which Piramal Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Piramal Pharma is ₹220.90 and 52-week low of Piramal Pharma is ₹132.50 as on Jul 10, 2026.
The Piramal Pharma has shown returns of 3.03% over the past day, 7.63% for the past month, 21.22% over 3 months, -11.76% over 1 year, 25.68% across 3 years, and -1.11% over 5 years.
P/E ratio of and PB ratio of Piramal Pharma are -72.34 and 2.89 on Jul 10, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global